Obesity - orlistat (replaced by CG43)
Orlistat for the treatment of obesity in adults
| Guidance type: Technology appraisal |
| Date issued: March 2001 |
We will consult on our review plans for this guidance in February 2004. |
| Reference: TA22 |
SummaryThis guidance is obsolete and has been replaced by CG43 Obesity. |
| Top |
DocumentsFor healthcare professionals
For patients, carers and the public
Background information |
Implementing this guidanceAny further information NICE has produced to help the NHS implement this guideline locally is linked to below:
|
| Top |
